AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines

(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) aims to deliver $80 billion in total revenue by 2030, up from $45.8 billion in 2023. The target will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and by launching an expec https://www.nasdaq.com/articles/astrazeneca-targets-$80-bln-revenue-by-2030-plans-to-launch-20-new-medicines